Vanarix has developed a new generation of cell therapy to produce high-quality hyaline cartilage mini-grafts, named Cartibeads, which resemble native tissue. Cartibeads are bio-engineered from allogeneic chondrocytes and release their own hyaline matrix. When implanted during minimally invasive arthroscopic surgery, Cartibeads can completely self-integrate into cartilage lesions and thus regenerate the tissue. Cartibeads are designed for the treatment of cartilage defects in traumatic and osteoarthritic joints.
Externer Link zu Vanarix
Avenue Mon-Repos 14
Lausanne, Vaud (fr) 1005, CH
Vanarix/Starlab, route de la Corniche 5
Epalinges, 1066, CH
Vanarix hat dies direkt geteilt
Following successful first clinical trials, Biopôle-based Vanarix has raised CHF 4 million from new private investors. This funding will finance the upcoming clinical trial and support the implementation of automated manufacturing processes for Cartibeads, making this treatment accessible to a larger patient population. Vannary Tieng, PhD, MBA Alessandra de Picciotto Vanarix Biopôle Lausanne https://lnkd.in/gRYqmgTv
Vanarix hat dies direkt geteilt
Proud of my team: Laura Bengtsson del Barrio and Yassir DIB 😊 at Biopôle Lausanne - Cartibeads, bio-engineered cartilage mini-implants, that self-integrate into the cartilage lesion of the knee and ressemble native cartilage, are the subject of a new clinical trial with the new allogeneic generation at HUG - Hôpitaux Universitaires de Genève, Ente Ospedaliero Cantonale (EOC), Hirslanden Genève, Universitätsklinik Balgrist - Advantages : For patients: a single surgical procedure for implantation For surgeons: ready-to-use products Many thanks to our surgeons/ investigators collaborating in this study Menetrey Jacques, Philippe Tscholl, Luca Deabate, @Delcogliano Marco, Sandro Fucentese, Olivier Lepage (for horse transplantation) at VetAgro Sup Many thanks also to our supporters, our private investors, Innosuisse, Etat de Vaud #cartilagerepair, #osteoarthritis, #kneepain, #regenerativemedicine, #veterinary, #equine, #allogeneic #celltherapy
Proud to have Cartibeads treatments cited by AGEFI, Nouvelle Agence Économique et Financière . Thanks Sophie Marenne . A clinical study with the new geneation of Cartibeads is currently underway at HUG - Hôpitaux Universitaires de Genève , Ente Ospedaliero Cantonale (EOC), Universitätsklinik Balgrist, Hirslanden Genève with the following investigators Philippe Tscholl Menetrey Jacques Sandro Fucentese @Marco Delcogliano and Luca Deabate
Il n'y a pas que l'#IA dans la tech: le World Economic Forum le souligne dans la dernière édition du Top 10 Emerging Technologies. Petit tour d'horizon, non exhaustif, des projets helvétiques liés à ces thématiques d’avenir Lennig Pedron, Jamie Paik, Julia Schmale, CSEM, Innosuisse, Lucerne University of Applied Sciences and Arts, Venturelab, EPFL, Tune Insight, Decentriq, DuoKey, Almer Technologies, Vanarix, Arrhenius AG, Scanvio Medical, Adaptyv Bio, Trust Valley, AGEFI, Nouvelle Agence Économique et Financière
so great🤩!!
𝐊𝐞𝐧𝐳𝐨'𝐬 𝐟𝐢𝐫𝐬𝐭 𝐣𝐮𝐦𝐩 𝟔 𝐦𝐨𝐧𝐭𝐡𝐬 𝐚𝐟𝐭𝐞𝐫 𝐂𝐚𝐫𝐭𝐢𝐛𝐞𝐚𝐝𝐬 𝐭𝐫𝐚𝐧𝐬𝐩𝐥𝐚𝐧𝐭𝐚𝐭𝐢𝐨𝐧! 😍 🐎 💪 Kenzo a 4-year-old jumper suffering from a metacarpophalangeal lesion due to osteochondritis dissecans received Cartibeads produced from cartilage cells (chondrocytes) extracted and cultured from an 8-year-old adult donor horse. Many thanks to Prof Olivier Lepage, 🙏 VetAgro Sup, Marcy l'Etoile, France, for this transplantation in one of the most challenging joint locations in horses: Our Cartibeads can support the weight of a horse weighing over 500 kg! #cartilage , #regenerativemedicine , #orthopaedics , #stemcells , #veterinary , #osteoarthritis #cartilageregeneration Biopôle Lausanne